• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Diagnostic disparity of previous and revised American Thoracic Society guidelines for idiopathic pulmonary fibrosis.美国胸科学会特发性肺纤维化既往指南与修订后指南的诊断差异
Can Respir J. 2015 Mar-Apr;22(2):86-90. doi: 10.1155/2015/307893. Epub 2015 Jan 9.
2
Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study.特发性肺纤维化患者的慢性过敏性肺炎:一项前瞻性病例队列研究。
Lancet Respir Med. 2013 Nov;1(9):685-94. doi: 10.1016/S2213-2600(13)70191-7. Epub 2013 Oct 21.
3
[A comparison study of diagnostic value between the old and revised guidelines in patients with idiopathic pulmonary fibrosis].[特发性肺纤维化患者旧版与修订版指南诊断价值的比较研究]
Zhonghua Nei Ke Za Zhi. 2016 Feb;55(2):131-4. doi: 10.3760/cma.j.issn.0578-1426.2016.02.013.
4
Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.特发性肺纤维化诊断标准在临床实践中的意义:来自澳大利亚特发性肺纤维化注册研究的分析。
Respirology. 2019 Apr;24(4):361-368. doi: 10.1111/resp.13427. Epub 2018 Oct 17.
5
Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis.支气管肺泡灌洗在特发性肺纤维化诊断中的意义
Am J Respir Crit Care Med. 2009 Jun 1;179(11):1043-7. doi: 10.1164/rccm.200808-1313OC. Epub 2009 Feb 26.
6
Comparisons of Prognosis between Surgically and Clinically Diagnosed Idiopathic Pulmonary Fibrosis Using Gap Model: A Korean National Cohort Study.使用间隙模型比较手术诊断与临床诊断的特发性肺纤维化的预后:一项韩国全国队列研究。
Medicine (Baltimore). 2016 Mar;95(11):e3105. doi: 10.1097/MD.0000000000003105.
7
Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis.特发性肺纤维化/隐源性纤维性肺泡炎诊断临床标准的潜在局限性。
Respiration. 2004 Mar-Apr;71(2):165-9. doi: 10.1159/000076678.
8
Assessment of current practice in the diagnosis and therapy of idiopathic pulmonary fibrosis.特发性肺纤维化诊断与治疗的当前实践评估
Respir Med. 2008 Sep;102(9):1342-8. doi: 10.1016/j.rmed.2008.03.018. Epub 2008 Jul 14.
9
The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF)--practical implications.特发性肺纤维化(IPF)的 ATS/ERS/JRS/ALAT 诊断标准修订版——实际意义。
Respir Res. 2013;14 Suppl 1(Suppl 1):S2. doi: 10.1186/1465-9921-14-S1-S2. Epub 2013 Apr 16.
10
Managing diagnostic procedures in idiopathic pulmonary fibrosis.特发性肺纤维化的诊断程序管理。
Eur Respir Rev. 2013 Jun 1;22(128):158-62. doi: 10.1183/09059180.00001213.

引用本文的文献

1
Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis.与特发性肺纤维化相比,新型冠状病毒肺炎后肺纤维化的临床病理概述
Biomedicines. 2023 Jun 17;11(6):1739. doi: 10.3390/biomedicines11061739.
2
Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations.特发性肺纤维化:诊断与临床表现
Clin Med Insights Circ Respir Pulm Med. 2016 Sep 6;9(Suppl 1):163-71. doi: 10.4137/CCRPM.S39897. eCollection 2015.

本文引用的文献

1
Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial.高分辨率 CT 诊断影像学无蜂窝肺表现或表现轻微的特发性肺纤维化患者:一项随机对照试验的二次分析。
Lancet Respir Med. 2014 Apr;2(4):277-84. doi: 10.1016/S2213-2600(14)70011-6. Epub 2014 Feb 18.
2
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.美国胸科学会/欧洲呼吸学会官方声明:特发性间质性肺炎的国际多学科分类的更新。
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48. doi: 10.1164/rccm.201308-1483ST.
3
The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF)--practical implications.特发性肺纤维化(IPF)的 ATS/ERS/JRS/ALAT 诊断标准修订版——实际意义。
Respir Res. 2013;14 Suppl 1(Suppl 1):S2. doi: 10.1186/1465-9921-14-S1-S2. Epub 2013 Apr 16.
4
Prevalence and prognosis of unclassifiable interstitial lung disease.无法分类的间质性肺疾病的患病率和预后。
Eur Respir J. 2013 Sep;42(3):750-7. doi: 10.1183/09031936.00131912. Epub 2012 Dec 6.
5
An earlier and more confident diagnosis of idiopathic pulmonary fibrosis.更早且更有把握地诊断特发性肺纤维化。
Eur Respir Rev. 2012 Jun 1;21(124):141-6. doi: 10.1183/09059180.00000812.
6
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.泼尼松、硫唑嘌呤和 N-乙酰半胱氨酸治疗肺纤维化。
N Engl J Med. 2012 May 24;366(21):1968-77. doi: 10.1056/NEJMoa1113354. Epub 2012 May 20.
7
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.特发性肺纤维化:诊断和管理的循证指南(美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会联合发布)
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
8
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.特发性肺纤维化诊断的临床预测因子。
Am J Respir Crit Care Med. 2010 Apr 15;181(8):832-7. doi: 10.1164/rccm.200906-0959OC. Epub 2010 Jan 7.
9
Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease.间质性肺疾病患者胶原血管病的确定。
Respir Med. 2009 Aug;103(8):1152-8. doi: 10.1016/j.rmed.2009.02.009. Epub 2009 Mar 21.
10
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).美国胸科学会。特发性肺纤维化:诊断与治疗。国际共识声明。美国胸科学会(ATS)和欧洲呼吸学会(ERS)。
Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):646-64. doi: 10.1164/ajrccm.161.2.ats3-00.

美国胸科学会特发性肺纤维化既往指南与修订后指南的诊断差异

Diagnostic disparity of previous and revised American Thoracic Society guidelines for idiopathic pulmonary fibrosis.

作者信息

Fidler Lee, Shapera Shane, Mittoo Shikha, Marras Theodore K

出版信息

Can Respir J. 2015 Mar-Apr;22(2):86-90. doi: 10.1155/2015/307893. Epub 2015 Jan 9.

DOI:10.1155/2015/307893
PMID:25575178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4390017/
Abstract

BACKGROUND

A revised guideline for the diagnosis of idiopathic pulmonary fibrosis (IPF) was formulated by the American Thoracic Society (ATS) in 2011 to improve disease diagnosis and provide a simplified algorithm for clinicians. The impact of these revisions on patient classification, however, remain unclear.

OBJECTIVE

To examine the concordance between diagnostic guidelines to understand how revisions impact patient classification.

METHODS

A cohort of 54 patients with either suspected IPF or a working diagnosis of IPF was evaluated in a retrospective chart review, in which patient data were examined according to previous and revised ATS guidelines. Patient characteristics influencing the fulfillment of diagnostic criteria were compared using one-way ANOVA and χ(2) tests.

RESULTS

Revised and previous guideline criteria for IPF were met in 78% and 83% of patients, respectively. Revised guidelines modified a classification based on previous guidelines in 28% of cases. Fifteen percent of patients meeting previous ATS guidelines failed to meet revised criteria due to a lack of honeycombing on high-resolution computed tomography and the absence of a surgical lung biopsy. Patients failing to meet previous and revised diagnostic criteria for IPF were younger.

CONCLUSION

The revised guidelines for the diagnosis of IPF classify a substantial proportion of patients differently than the previous guidelines.

摘要

背景

美国胸科学会(ATS)于2011年制定了特发性肺纤维化(IPF)诊断的修订指南,以改善疾病诊断并为临床医生提供简化的算法。然而,这些修订对患者分类的影响仍不明确。

目的

检查诊断指南之间的一致性,以了解修订如何影响患者分类。

方法

通过回顾性病历审查对54例疑似IPF或已确诊IPF的患者进行队列评估,根据ATS之前和修订后的指南检查患者数据。使用单因素方差分析和χ²检验比较影响诊断标准满足情况的患者特征。

结果

分别有78%和83%的患者符合IPF的修订和之前的指南标准。修订后的指南在28%的病例中修改了基于之前指南的分类。15%符合之前ATS指南的患者由于高分辨率计算机断层扫描上缺乏蜂窝状改变且未进行外科肺活检而未达到修订后的标准。未达到IPF之前和修订后诊断标准的患者年龄较小。

结论

IPF诊断的修订指南对相当一部分患者的分类与之前的指南不同。